BRIEF-Sagent Pharmaceuticals buys product portfolio from Teva Pharmaceutical
June 16 Sagent Pharmaceuticals Inc : * Sagent Pharmaceuticals acquires product portfolio from Teva Pharmaceutical Industries Ltd. * Acquired portfolio is expected to generate $40 to $50 million in revenue on an annualized basis. * Deal for $40 million.
Source: pharmaceutical – Google News
Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd